A robust and efficient alluvial filtration method for the clarification of adeno-associated viruses from crude cell lysates

被引:9
作者
Meierrieks, Frederik [1 ]
Pickl, Andreas [1 ,4 ]
Wolff, Michael W. [2 ,3 ,5 ]
机构
[1] Sartorius Lab Instruments GmbH & Co KG, Lab Essentials Applicat Dev, Otto Brenner Str 20, D-37079 Gottingen, Germany
[2] Univ Appl Sci Mittelhessen THM, Inst Bioproc Engn & Pharmaceut Technol, Giessen, Germany
[3] Fraunhofer Inst Mol Biol & Appl Ecol IME, Giessen, Germany
[4] Sartorius Lab Instruments GmbH & Co KG, Otto Brenner Str 20, D-37079 Giessen, Germany
[5] Univ Appl Sci Mittelhessen THM, Wiesenstr 14, D-35390 Giessen, Germany
关键词
Clarification; Diatomaceous earth; Adeno-associated virus; Filtration; Downstream processing; DIATOMACEOUS-EARTH; GENE-THERAPY; AAV; VECTOR; PURIFICATION; PLATFORM; BIOLOGY;
D O I
10.1016/j.jbiotec.2023.03.010
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Adeno-associated virus (AAV) based vectors have recently been gaining importance as DNA delivery systems. Efficient downstream processing of AAV remains a major challenge as serotypes differ in physicochemical properties, making it difficult to design uniform purification processes. Clarification of AAV is an especially critical step. Harvesting of AAV, like other viruses, often requires cell lysis, resulting in a difficult-to-filter cell lysate. In this study, we evaluated the applicability of diatomaceous earth (DE) as a filter aid for clarification of AAV crude cell lysates. DE filtration proved to be a viable clarification method for AAV2, AAV5 and AAV8. Based on a design of experiment approach, the DE concentration was identified as the main factor influencing AAV particle loss. The loss of AAV during DE filtration was limited to < 2% by maintaining the DE quantity below 0.181 mg DE/1010 AAV. Use of DE reduced manual handling time 3-fold and increased the filter capacity 3.5-fold compared to filtration combined with a prior centrifugation step. Moreover, we showed that the DE type had only a minor influence on the filtration performance. This study demonstrated that filtration with DE as a filter aid is an efficient clarification method for different AAV serotypes.
引用
收藏
页码:31 / 41
页数:11
相关论文
共 51 条
[1]   Moving from the bench towards a large scale, industrial platform process for adeno-associated viral vector purification [J].
Adams, Benjamin ;
Bak, Hanne ;
Tustian, Andrew D. .
BIOTECHNOLOGY AND BIOENGINEERING, 2020, 117 (10) :3199-3211
[2]   Metabolic biotinylation provides a unique platform for the purification and targeting of multiple AAV vector serotypes [J].
Arnold, Gregory S. ;
Sasser, A. Kate ;
Stachler, Matthew D. ;
Bartlett, Jeffrey S. .
MOLECULAR THERAPY, 2006, 14 (01) :97-106
[3]   ADENOVIRUS-ASSOCIATED DEFECTIVE VIRUS PARTICLES [J].
ATCHISON, RW ;
CASTO, BC ;
HAMMON, WM .
SCIENCE, 1965, 149 (3685) :754-&
[5]  
Bakr H., 2010, Asian Journal of Materials Science, V2, P121, DOI [10.3923/ajmskr.2010.121.136, DOI 10.3923/AJMSKR.2010.121.136, 10.3923/ajmskr.2010.121.136.]
[6]   Basic Biology of Adeno-Associated Virus (AAV) Vectors Used in Gene Therapy [J].
Balakrishnan, Balaji ;
Jayandharan, Giridhara R. .
CURRENT GENE THERAPY, 2014, 14 (02) :86-100
[7]   Robust AAV Genotyping Based on Genetic Distances in Rep Gene That Are Maintained by Ubiquitous Recombination [J].
Beloukhova, Marina, I ;
Lukashev, Alexander N. ;
Volchkov, Pavel Y. ;
Zamyatnin, Andrey A., Jr. ;
Deviatkin, Andrei A. .
VIRUSES-BASEL, 2022, 14 (05)
[8]   AAV: An Overview of Unanswered Questions [J].
Berns, Kenneth I. ;
Muzyczka, Nicholas .
HUMAN GENE THERAPY, 2017, 28 (04) :308-313
[9]   Clarification of vaccines: An overview of filter based technology trends and best practices [J].
Besnard, Lise ;
Fabre, Virginie ;
Fettig, Michael ;
Gousseinov, Elina ;
Kawakami, Yasuhiro ;
Laroudie, Nicolas ;
Scanlan, Claire ;
Pattnaik, Priyabrata .
BIOTECHNOLOGY ADVANCES, 2016, 34 (01) :1-13
[10]   Scalable Production of AAV Vectors in Orbitally Shaken HEK293 Cells [J].
Blessing, Daniel ;
Vachey, Gabriel ;
Pythoud, Catherine ;
Rey, Maria ;
Padrun, Vivianne ;
Wurm, Florian M. ;
Schneider, Bernard L. ;
Deglon, Nicole .
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT, 2019, 13 :14-26